Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Present at SG Cowen Health Care Conference

WILMINGTON, Mass., Mar 1, 2005 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the SG Cowen 25th Annual Health Care Conference in Boston, Massachusetts, on Tuesday, March 15, 2005, at 9:40 a.m. ET.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of Charles River's website, http://ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after the presentation and will remain available until March 22, 2005.

SOURCE: Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.
Director, Investor Relations
Susan E. Hardy, 978-658-6000 Ext. 1616

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)